Cancer-associated blood clots are not a new problem, but they remain a deadly one. In a powerful new article published this week, Dr. Alok Khorana, chair of NBCA’s Medical and Scientific Advisory Board, underscores just how serious the issue is and why advocacy matters. Dr. Khorana highlights research showing that people with cancer who develop blood clots are more likely to die, experience longer hospital stays, and face higher medical costs than those without clots. Pulmonary embolism, in part